Transforming Cancer Care: The EU-Onco-Platform Reporting Solution
Advancing NGS bioinformatics analysis in Precision Oncology in Europe through the Instand-NGS4P project 1.
Advancing NGS bioinformatics analysis in Precision Oncology in Europe through the Instand-NGS4P project 1.
Espoo, April 7th, 2025. Saide Genomics has signed commercial contracts with UK-based Nonacus and Finland-based Euformatics to supply consumables and
Espoo, March 27th, 2025. Euformatics has signed a commercial contract with India-based genomics company Bencos Healthcare Solution Pvt Ltd to
Introduction Next-Generation Sequencing (NGS) is transforming disease diagnosis and treatment by enabling fast and precise genetic analysis.
Introduction Clinical diagnostics are essential in identifying and managing medical conditions. Among its many tools, genetic testing stands
Genomics is transforming the landscape of modern medicine, paving the way for personalized treatments and improved approaches to disease
Since 2021, omnomicsNGS has held the CE-IVD mark under the In Vitro Diagnostics Directive (IVDD 98/79/EC). Euformatics Quality Manager Ashwini